Detailed View
NKTR - Nektar Therapeutics
Latest filing: 2026-06-30 | Reporting: gaap
Market Cap
1,261,583,616
Adj EBIT (TTM)
-140,732,000
Enterprise Value
577,242,616
Last Price
36.95
Earnings Yield
-24.38%
Return on Capital
-13.74%
Capital
1,024,144,000
1Y Price Chart
Last Price: $36.95
1Y Change: -41.16%
As of 2026-11-02 | 1Y Change: -41.16%
Company Summary
Loading summary...
| endDate | formType | fiscalYear | Revenue | OperatingIncomeLoss |
|---|---|---|---|---|
| 2026-06-30 | 10-Q | 2026 | 10,131,000 | -42,341,000 |
| 2026-03-31 | 10-Q | 2026 | 10,861,000 | -39,054,000 |
| 2025-12-31 | 10-K (Q4 derived) | 2025 | 21,807,000 | -27,665,000 |
| 2025-09-30 | 10-Q | 2025 | 11,790,000 | -31,672,000 |
| 2025-06-30 | 10-Q | 2025 | 11,175,000 | -36,230,000 |
| 2025-03-31 | 10-Q | 2025 | 10,460,000 | -44,535,000 |
| 2024-12-31 | 10-K (Q4 derived) | 2024 | 29,175,000 | 14,348,000 |
| 2024-09-30 | 10-Q | 2024 | 24,124,000 | -34,345,000 |
Notice something wrong?
Submit a quick report with a snapshot of the values you are seeing.